Liu Chunyao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liu Chunyao has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Jiang Ruihan
Department of Cardiac Ultrasound The Affiliated Hospital of Qingdao University Qingdao China
2 shared publicationsLi Kai
Department of Cardiac Ultrasound The Affiliated Hospital of Qingdao University Qingdao China
2 shared publicationsLin Mingming
Department of Cardiac Ultrasound The Affiliated Hospital of Qingdao University Qingdao China
2 shared publicationsLv Qifeng
Department of Cardiac Ultrasound The Affiliated Hospital of Qingdao University Qingdao China
2 shared publicationsSong Xiaoxia
Department of Cardiac Ultrasound The Affiliated Hospital of Qingdao University Qingdao China
2 shared publicationsSun Juanjuan
Department of Cardiac Ultrasound The Affiliated Hospital of Qingdao University Qingdao China
2 shared publications
Latest Publications
- 18 May 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (5)
Cover Image: Volume 49 Issue 5
- Open Access
- 30 April 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (5) , e70285
Quantitative Assessment of Myocardial Perfusion in Physiological and Pathological Hypertrophy Using Myocardial Contrast Echocardiography
Objective: To quantitatively evaluate myocardial perfusion levels in patients with physiological and pathological myocardial hypertrophy using myocardial contrast echocardiography (MCE), and to investigate the diagnostic value of MCE parameters for differentiating between these conditions. Methods: From June 2023 to December 2024, 25 hypertensive patients with myocardial hypertrophy (pathological hypertrophy group), 25 healthy athletes (physiological hypertrophy group), and 25 healthy controls were enrolled. All participants underwent two‐dimensional echocardiography and MCE. Myocardial perfusion parameters—peak intensity ( A ‐value), wash‐in slope ( β ‐value), and myocardial blood flow (MBF)—were quantified using a 17‐segment model. Differences in perfusion parameters were compared, and receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic efficacy. Results: Compared with controls, the physiological hypertrophy group showed significantly increased peak intensity ( A ‐value) and MBF ( p < 0.05), whereas the pathological hypertrophy group exhibited decreased A‐value, slope rate (β ‐value), and MBF ( p < 0.05). Intragroup segmental analysis revealed that in pathological hypertrophy, the basal segments had significantly lower A‐value and MBF compared to mid and apical segments ( p < 0.05). Intermural comparison demonstrated that in both control and physiological hypertrophy groups, the free wall had lower A ‐value and MBF than the septum ( p < 0.05). In contrast, pathological hypertrophy showed reduced A ‐value but increased β ‐value in the free wall ( p < 0.05). ROC curve analysis identified an optimal cutoff value of A > 8.13 dB (AUC = 0.904) for discriminating exercise‐induced physiological hypertrophy from hypertension‐induced pathological hypertrophy. Conclusion: MCE enables quantitative assessment of myocardial perfusion in hypertrophic patients. The A value, reflecting microvascular density, serves as a reliable discriminator between physiological and pathological hypertrophy.
- 30 April 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (5) , e70285
Open AccessQuantitative Assessment of Myocardial Perfusion in Physiological and Pathological Hypertrophy Using Myocardial Contrast Echocardiography
Objective: To quantitatively evaluate myocardial perfusion levels in patients with physiological and pathological myocardial hypertrophy using myocardial contrast echocardiography (MCE), and to investigate the diagnostic value of MCE parameters for differentiating between these conditions. Methods: From June 2023 to December 2024, 25 hypertensive patients with myocardial hypertrophy (pathological hypertrophy group), 25 healthy athletes (physiological hypertrophy group), and 25 healthy controls were enrolled. All participants underwent two‐dimensional echocardiography and MCE. Myocardial perfusion parameters—peak intensity ( A ‐value), wash‐in slope ( β ‐value), and myocardial blood flow (MBF)—were quantified using a 17‐segment model. Differences in perfusion parameters were compared, and receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic efficacy. Results: Compared with controls, the physiological hypertrophy group showed significantly increased peak intensity ( A ‐value) and MBF ( p < 0.05), whereas the pathological hypertrophy group exhibited decreased A‐value, slope rate (β ‐value), and MBF ( p < 0.05). Intragroup segmental analysis revealed that in pathological hypertrophy, the basal segments had significantly lower A‐value and MBF compared to mid and apical segments ( p < 0.05). Intermural comparison demonstrated that in both control and physiological hypertrophy groups, the free wall had lower A ‐value and MBF than the septum ( p < 0.05). In contrast, pathological hypertrophy showed reduced A ‐value but increased β ‐value in the free wall ( p < 0.05). ROC curve analysis identified an optimal cutoff value of A > 8.13 dB (AUC = 0.904) for discriminating exercise‐induced physiological hypertrophy from hypertension‐induced pathological hypertrophy. Conclusion: MCE enables quantitative assessment of myocardial perfusion in hypertrophic patients. The A value, reflecting microvascular density, serves as a reliable discriminator between physiological and pathological hypertrophy.